Doctor of Optometry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Bradley Powers

Optometrist Columbia, SC Doctor of Optometry

NPI 1881141562 CMS profile 4071052

470 Town Center Pl Ste 5, Columbia, SC 29229

Open in the dashboard

General payments

$6,878

86 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Bradley Powers of Columbia, SC is reported in the CMS Open Payments database as having received $6,878 across 86 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Optometrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $157 2
2024 General $688 9
2023 General $3,010 14
2022 General $745 23
2021 General $303 9
2020 General $275 5
2019 General $1,700 24

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Bradley Powers
  • Optometrist median
  • Middle half of Optometrist
  • National median

In program year 2025, general payments to Bradley Powers were reported at $157. Among 35,373 Optometrist profiles paid that year, the median was $204 and the middle half received between $87 and $464.

Show as a table
Year Bradley Powers Optometrist median Middle half National median
2019 $1,700 $159 $67–$371 $163
2020 $275 $72 $29–$165 $114
2021 $303 $125 $46–$292 $132
2022 $745 $162 $66–$374 $149
2023 $3,010 $177 $72–$406 $160
2024 $688 $188 $77–$427 $164
2025 $157 $204 $87–$464 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. CooperVision Inc. $3,000 15 payments
  2. Alcon Vision LLC $1,913 39 payments
  3. Bausch & Lomb Americas Inc. $828 11 payments
  4. Glaukos Corporation $486 6 payments
  5. Bausch & Lomb, a division of Bausch Health US, LLC $327 6 payments
  6. Johnson & Johnson Vision Care, Inc. $216 6 payments
  7. Allergan Inc. $76 1 payment
  8. ABB Con-Cise Optical Group LLC $17 1 payment
  9. Indivior Inc. $17 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,711 81 payments
  2. Travel and Lodging $3,167 5 payments
Products named General payments · program years 2019–2025
  1. CVI Contact Lens $2,810 11 payments
  2. DAILIES $1,511 19 payments
  3. INFUSE $953 12 payments
  4. AIR OPTIX $596 3 payments
  5. Radius $260 4 payments
  6. Acuvue $216 6 payments
  7. TOTAL30 $187 9 payments
  8. MyDay Contact Lens $175 3 payments
  9. ULTRA $166 3 payments
  10. Precision 1 $128 8 payments
  11. Other $641 14 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

86 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Optometrist in South Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record